Centre for Cancer Genomics and Computational Biology
In the Centre for Genomics and Computational Biology, we employ unbiased high-throughput sequencing, mass spectrometry and multispectral imaging of tumour samples to gain unique insights into cancer evolution, genetics and cell signalling through from premalignancy to metastatic disease. We are internationally recognised for our work on lymphoma, leukaemia and gastrointestinal cancers, and the creation of computational tools to extract maximum value from Big Data. Our ambition is to see translation of new knowledge into improvements in early cancer detection and precision medicine.
Contact us
Centre Lead: Professor Jude Fitzgibbon
Deputy Centre Lead: Professor Trevor Graham
John Vane Science Centre,
Charterhouse Square,
London EC1M 6BQ
Recent Publications
- Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR. Nat Metab (2019) 1(8):775-789. PMID: 31579886
- Measuring Clonal Evolution in Cancer with Genomics. Annu Rev Genomics Hum Genet (2019) 20:309-329. PMID: 31059289
- Quantification of Crypt and Stem Cell Evolution in the Normal and Neoplastic Human Colon. Cell Rep (2019) 27(8):2524. PMID: 31116993
- Evolutionary history of human colitis-associated colorectal cancer. Gut (2019) 68(6):985-995. PMID: 29991641
- The feedback between selection and demography shapes genomic diversity during coevolution. Science Advances (2019) 5(10) DOI: 10.1126/sciadv.aax0530
Latest News
- Pedro Cutillas was awarded funding from Innovate UK and private investors totalling £950k to found Kinomica Ltd., a QMUL spin-out company that aims to translate research from the Cutillas group into companion diagnostics.
- Kit Curtius was awarded CRUK Early Detection Primer Award to study the molecular ageing of premalignancy Barrett’s oesophagus in a population-representative sample of patients spanning paediatric to older age groups, co-PI Prof Helen Coleman Queen’s University of Belfast.
- Jun Wang, co-investigator led by Prof Irene Leigh Institute of Dentistry QMUL, was awarded the Sanofi and Regeneron Investigator Sponsored Studies (ISS) Program, £639K, to investigate “Personalised medicine for immunotherapy of cutaneous squamous cell carcinoma (PERMEDID)”.
